The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates


Authors: 
Jones Bryan E., Brown-Augsburger Patricia L., Corbett Kizzmekia S., Westendorf Kathryn, Davies Julian, Cujec Thomas P., Wiethoff Christopher M., Blackbourne Jamie L., Heinz Beverly A., Foster Denisa, Higgs Richard E., Balasubramaniam Deepa, Wang Lingshu, Zhang Yi, Yang Eun Sung, Bidshahri Roza, Kraft Lucas, Hwang Yuri, Žentelis Stefanie, Jepson Kevin R., Goya Rodrigo, Smith Maia A., Collins David W., Hinshaw Samuel J., Tycho Sean A., Pellacani Davide, Xiang Ping, Muthuraman Krithika, Sobhanifar Solmaz, Piper Marissa H., Triana Franz J., Hendle Jorg, Pustilnik Anna, Adams Andrew C., Berens Shawn J., Baric Ralph S., Martinez David R., Cross Robert W., Geisbert Thomas W., Borisevich Viktoriya, Abiona Olubukola, Belli Hayley M., de Vries Maren, Mohamed Adil, Dittmann Meike, Samanovic Marie I., Mulligan Mark J., Goldsmith Jory A., Hsieh Ching-Lin, Johnson Nicole V., Wrapp Daniel, McLellan Jason S., Barnhart Bryan C., Graham Barney S., Mascola John R., Hansen Carl L., Falconer Ester
Date of publication: 
Wednesday, 12 May, 2021
Volume: 
13
Issue: 
593
Pages: 
eabf1906
EVAg connections: 
Research funded by EVAg
Published by EVAg end-user